Evidence Hub

Green mycosynthesis of small-sized silver nanoparticles (ss-AgNPs) from endophytic Fusarium solani and their multi-target biomedical profiles

Madavi TA, Yerpude ST, Dongre UJ, Upadhye VJ, Rai AR

Scientific reports, 2026

Abstract

The present work focuses on the mycosynthesis, physicochemical profiling and biological evaluation of small-sized silver nanoparticles (ss-AgNPs) synthesized through a fungal-mediated green approach using endophytic Fusarium solani. The UV-Visible spectrum exhibited a distinct surface plasmon resonance (SPR) peak at 499 nm, indicating the successful reduction of Ag⁺ ions to Ag0, while XRD and TEM analyses revealed crystalline, spherical ss-AgNPs with an average particle size of 6.13 nm and a face-centered cubic (fcc) crystalline structure. FTIR spectra indicated the contribution of biomolecules containing functional groups such as amine, hydroxyl and carbonyl groups as reducing and stabilizing agents. The zeta potential (- 6.9 mV) suggests moderate colloidal stability. Biologically, the ss-AgNPs demonstrated broad-spectrum antibacterial activity, significant anti-biofilm inhibition (up to 73.53%), potent antioxidant potential (IC50 = 35.85 µg/mL), and strong anti-inflammatory activity in protein denaturation (IC50 = 22.90 µg/mL). The nanoparticles also exhibited marked cytotoxicity against A549 lung cancer cells (IC50 ≈ 25-50 µg/mL) and moderate α-amylase inhibitory activity (IC50 = 93.82 µg/mL), suggesting anti-diabetic potential. These findings confirm that fungal-mediated synthesis is a sustainable, eco-friendly, and efficient method for producing multifunctional ss-AgNPs with diverse biomedical applications in antimicrobial, antioxidant, anti-inflammatory, and anticancer…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free